Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation

被引:383
作者
Di Ianni, Mauro [1 ,2 ]
Falzetti, Franca [2 ]
Carotti, Alessandra [2 ]
Terenzi, Adelmo [2 ]
Castellino, Flora
Bonifacio, Elisabetta [2 ]
Del Papa, Beatrice [2 ]
Zei, Tiziana [2 ]
Ostini, Roberta Iacucci [2 ]
Cecchini, Debora [2 ]
Aloisi, Teresa [2 ]
Perruccio, Katia [2 ]
Ruggeri, Loredana [2 ]
Balucani, Chiara [2 ]
Pierini, Antonio [2 ]
Sportoletti, Paolo [2 ]
Aristei, Cynthia [2 ]
Falini, Brunangelo [2 ]
Reisner, Yair [3 ]
Velardi, Andrea [2 ]
Aversa, Franco [2 ]
Martelli, Massimo F. [2 ]
机构
[1] Univ Aquila, Chair Hematol, Dept Internal Med & Publ Hlth, I-67100 Laquila, Italy
[2] Univ Perugia, Dept Clin & Expt Med, Hematol & Clin Immunol Sect, I-06100 Perugia, Italy
[3] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel
关键词
VERSUS-HOST-DISEASE; REGULATORY T-CELLS; BONE-MARROW-TRANSPLANTATION; ADOPTIVE IMMUNOTHERAPY; ACUTE-LEUKEMIA; HIGH-RISK; MEGADOSE; BARRIERS; DONORS;
D O I
10.1182/blood-2010-10-311894
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hastening posttransplantation immune reconstitution is a key challenge in human leukocyte antigen (HLA)-haploidentical hematopoietic stem-cell transplantation (HSCT). In experimental models of mismatched HSCT, T-regulatory cells (Tregs) when coinfused with conventional T cells (Tcons) favored posttransplantation immune reconstitution and prevented lethal graft-versus-host disease (GVHD). In the present study, we evaluated the impact of early infusion of Tregs, followed by Tcons, on GVHD prevention and immunologic reconstitution in 28 patients with high-risk hematologic malignancies who underwent HLA-haploidentical HSCT. We show for the first time in humans that adoptive transfer of Tregs prevented GVHD in the absence of any posttransplantation immunosuppression, promoted lymphoid reconstitution, improved immunity to opportunistic pathogens, and did not weaken the graft-versus-leukemia effect. This study provides evidence that Tregs are a conserved mechanism in humans. (Blood. 2011; 117(14):3921-3928)
引用
收藏
页码:3921 / 3928
页数:8
相关论文
共 24 条
[1]   Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation [J].
Amrolia, Persis J. ;
Muccioli-Casadei, Giada ;
Huls, Helen ;
Adams, Stuart ;
Durett, April ;
Gee, Adrian ;
Yvon, Eric ;
Weiss, Heidi ;
Cobbold, Mark ;
Gaspar, H. Bobby ;
Rooney, Cliona ;
Kuehnle, Ingrid ;
Ghetie, Victor ;
Schindler, John ;
Krance, Robert ;
Heslop, Helen E. ;
Veys, Paul ;
Vitetta, Ellen ;
Brenner, Malcolm K. .
BLOOD, 2006, 108 (06) :1797-1808
[2]  
Arcese W, 2006, HAEMATOL-HEMATOL J, V91, P223
[3]   SUCCESSFUL ENGRAFTMENT OF T-CELL-DEPLETED HAPLOIDENTICAL 3-LOCI INCOMPATIBLE TRANSPLANTS IN LEUKEMIA PATIENTS BY ADDITION OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR-MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS TO BONE-MARROW INOCULUM [J].
AVERSA, F ;
TABILIO, A ;
TERENZI, A ;
VELARDI, A ;
FALZETTI, F ;
GIANNONI, C ;
IACUCCI, R ;
ZEI, T ;
MARTELLI, MP ;
GAMBELUNGHE, C ;
ROSSETTI, M ;
CAPUTO, P ;
LATINI, P ;
ARISTEI, C ;
RAYMONDI, C ;
REISNER, Y ;
MARTELLI, MF .
BLOOD, 1994, 84 (11) :3948-3955
[4]   Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype [J].
Aversa, F ;
Tabilio, A ;
Velardi, A ;
Cunningham, I ;
Terenzi, A ;
Falzetti, F ;
Ruggeri, L ;
Barbabietola, G ;
Aristei, C ;
Latini, P ;
Reisner, Y ;
Martelli, MF .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (17) :1186-1193
[5]   Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse [J].
Aversa, F ;
Terenzi, A ;
Tabilio, A ;
Falzetti, F ;
Carotti, A ;
Ballanti, S ;
Felicini, R ;
Falcinelli, F ;
Velardi, A ;
Ruggeri, L ;
Aloisi, T ;
Saab, JP ;
Santucci, A ;
Perruccio, K ;
Martelli, MP ;
Mecucci, C ;
Reisner, Y ;
Martelli, MF .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (15) :3447-3454
[6]   MEGADOSE OF T-CELL-DEPLETED BONE-MARROW OVERCOMES MHC BARRIERS IN SUBLETHALLY IRRADIATED MICE [J].
BACHARLUSTIG, E ;
RACHAMIM, N ;
LI, HW ;
LAN, FS ;
REISNER, Y .
NATURE MEDICINE, 1995, 1 (12) :1268-1273
[7]   Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study [J].
Ciceri, Fabio ;
Bonini, Chiara ;
Stanghellini, Maria Teresa Lupo ;
Bondanza, Attilio ;
Traversari, Catia ;
Salomoni, Monica ;
Turchetto, Lucia ;
Colombi, Scialini ;
Bernardi, Massimo ;
Peccatori, Jacopo ;
Pescarollo, Alessandra ;
Servida, Paolo ;
Magnani, Zulma ;
Perna, Serena K. ;
Valtolina, Veronica ;
Crippa, Fulvio ;
Callegaro, Luciano ;
Spoldi, Elena ;
Crocchiolo, Roberto ;
Fleischhauer, Katharina ;
Ponzoni, Maurilio ;
Vago, Luca ;
Rossini, Silvano ;
Santoro, Armando ;
Todisco, Elisabetta ;
Apperley, Jane ;
Olavarria, Eduardo ;
Slavin, Shimon ;
Weissinger, Eva M. ;
Ganser, Arnold ;
Stadler, Michael ;
Yannaki, Evangelia ;
Fassas, Athanasios ;
Anagnostopoulos, Achilles ;
Bregni, Marco ;
Stampino, Corrado Gallo ;
Bruzzi, Paolo ;
Bordignon, Claudio .
LANCET ONCOLOGY, 2009, 10 (05) :489-500
[8]   Full-intensity and reduced-intensity allogeneic stem cell transplantation in AML [J].
Craddock, C. F. .
BONE MARROW TRANSPLANTATION, 2008, 41 (05) :415-423
[9]   Immunomagnetic isolation of CD4+CD25+FoxP3+ natural T regulatory lymphocytes for clinical applications [J].
Di Ianni, M. ;
Del Papa, B. ;
Cecchini, D. ;
Bonifacio, E. ;
Moretti, L. ;
Zei, T. ;
Ostini, R. Iacucci ;
Falzetti, F. ;
Fontana, L. ;
Tagliapietra, G. ;
Maldini, C. ;
Martelli, M. F. ;
Tabilio, A. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2009, 156 (02) :246-253
[10]   CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation [J].
Edinger, M ;
Hoffmann, P ;
Ermann, J ;
Drago, K ;
Fathman, CG ;
Strober, S ;
Negrin, RS .
NATURE MEDICINE, 2003, 9 (09) :1144-1150